Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be...

|By:, SA News Editor

Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR)